Page last updated: 2024-10-28

gw8510 and Breast Cancer

gw8510 has been researched along with Breast Cancer in 1 studies

GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Tamoxifen resistance is a major roadblock in the treatment of patients with breast cancer."3.96Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction. ( Chen, CG; Li, J; Li, MY; Li, XQ; Li, ZN; Shu, Y; Wang, S; Zhao, XH, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, ZN1
Shu, Y1
Chen, CG1
Li, XQ1
Li, MY1
Zhao, XH1
Wang, S1
Li, J1

Other Studies

1 other study available for gw8510 and Breast Cancer

ArticleYear
Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction.
    Biochemical and biophysical research communications, 2020, 07-30, Volume: 528, Issue:3

    Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autophagy;

2020